Abstract
Organophosphorus (OP) and carbamate compounds have been utilized for a variety of purposes including use as therapeutic agents, agricultural chemicals, plasticizers, lubricants, flame retardants, and fuel additives. Many of the pesticides in use today belong to the OP or carbamate classes of compounds. Some OP compounds, the highly toxic nerve agents, have been developed for chemical warfare, whereas some carbamates have more recently been utilized as prophylactic drugs to prevent the devastating effects of nerve agent exposures (1,2). Although these agents exhibit a wide array of chemical structures, physicochemical properties, and toxicological potencies, the acute toxicity of most OP and carbamate pesticides is initiated by inhibition of the enzyme acetylcholinesterase (AChE, EC 3.1.1.7) in the peripheral and/or central nervous system (PNS/CNS)(3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sidell, F. R. and Borak, J. (1992) Chemical warfare agents: II. Nerve agents. Ann. Emerg. Med. 21, 865–871.
Ehrich, M. (1998) Organophosphates, in Encyclopedia of Toxicology ( Wexler, P., ed.), Academic Press, San Diego, CA, pp. 467–471.
Nostrandt, A. C., Padilla, S., and Moser, V. C. (1997) The relationship of oral chlorpyrifos effects on behavior, cholinesterase inhibition, and muscarinic receptor density in rat. Pharmacol. Biochem. Behay. 58, 15–23.
Gallo, M. A. and Lawryk, N. J. (1991) Organic phosphorus pesticides, in Handbook of Pesticide Toxicology ( Hayes, W. J. and Laws, E. R., eds.), Academic Press, San Diego, CA, pp. 917–1123.
Weiner, M. L. and Jortner, B. S. (1999) Organophosphate-induced delayed neurotoxicity of triarylphosphates. Neurotoxicology 20, 653–673.
Scopes, R. K. (1982). Maintenance of active enzymes, in Protein Purification, Principles and Practice, Springer Verlag, NY, pp. 185–200.
Hamilton, S. E., Dudman, A. P., DeJersey, J., Stoops, J. K., and Zerner, B. (1975) Organo-phosphate inhibitors: the reactions of bis(p-nitrophenyl)methyl phosphate with liver carboxylesterases and alpha-chymotrypsin. Biochim. Biophys. Acta 377, 282–296.
Johnson, M. K. and Clothier, B. (1980) Biochemical events in delayed neurotoxicity: is aging of chymotrypsin inhibited by saligenin cyclic phosphates a model for aging of neurotoxic esterase? Toxicol. Lett. 5, 95–98.
Mantle, D., Saleem, M. A., Williams, F. M., Wilkins, R. M., and Shakoori, A. R. (1997) Effect of pirimiphos-methyl on proteolytic enzyme activities in rat heart, kidney, brain and liver tissues in vivo. Clin. Chem. Acta 262, 89–97.
Saleem, M. A., Williams, F. M., Wilkins, R. M., Shakoori, A. R., and Mantle, D. (1998) Effect of tri-o-cresyl phosphate (TOCP) on proteolytic enzyme activities in mouse liver in vivo. J. Environ. Pathol. Toxicol. Oncol. 17, 69–73.
Pruett, S. B., Chambers, H. W., and Chambers, J. E. (1994) A comparative study of inhibition of acetylcholinesterase, trypsin, neuropathy target esterase, and spleen cell activation by structurally related organophosphorus compounds. J. Biochem. Toxicol. 9, 319–327.
Quistad, G. B. and Casida, J. E. (2000) Sensitivity of blood-clotting factors and digestive enzymes to inhibition by organophosphorus pesticides. J. Biochem. Mol. Toxicol. 14, 51–56.
Murumatsu, M. and Kuriyama, K. (1976) Effect of organophosphorus compounds on acetylcholine synthesis in brain. Jpn. J. Pharmacol. 26, 249–254.
DuBois, K. P., Doull, J., Salerno, P. R., and Coon, J. (1949) Studies on the toxicity and mechanisms of action ofp-nitrophenyl diethyl thionophosphate (parathion). J. Pharmacol. Exp. Ther. 95, 79–91.
Frederickson, T. (1958) Further studies on fluoro-phosphorylcholines. Pharmacological properties of two new analogues. Arch. Int. Pharmacodyn. 115, 474–482.
Bonner, T. I. (1989) The molecular basis of muscarinic receptor diversity. Trends Neurosci. 12, 148–151.
McGehee, D. S. and Role, L. W. (1995) Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Ann. Rev. Physiol. 57, 521–546.
Albuquerque, E. X., Alkondon, M., Pereira, E. F., Castro, N. G., Schrattenholz, A., Barbosa, C. T., et al. (1997) Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J. Pharmacol. Exp. Ther. 280, 1117–1136.
Bartles, E. and Nachmansohn, D. (1969) Organophosphate inhibitors of acetylcholine-receptor and —esterase tested on the electroplax. Arch. Biochem. Biophys. 133, 1–10.
Eldefrawi, M. E. and Eldefrawi, A. T. (1983) Neurotransmitter receptors as targets for pesticides. J. Environ. Sci. Health [B] 18, 65–88.
Bakry, N. M., el-Rashidy, A. H., Eldefrawi, A. T., and Eldefrawi, M. E. (1988) Direct actions of organophosphate anticholinesterases on nicotinic and muscarinic acetylcholine receptors. J. Biochem. Toxicol. 3, 235–259.
Seifert, S. A. and Eldefrawi, M. E. (1974) Affinity of myasthenia drugs to acetylcholinesterase and acetylcholine receptor. Biochem. Med. 10, 258–265.
Albuquerque, E. X., Deshpande, S. S., Kawabuchi, M., Aracava, Y., Idriss, M., Rickett, D. L., and Boyne, A. F. (1985) Multiple actions of anticholinesterase agents on chemosensitive synapses: molecular basis for prophylaxis and treatment of organophosphate poisoning. Fundam. Appl. Toxicol. 5, S182 - S203.
Shaw, K. P., Aracava, Y., Akaike, A., Daly, J. W., Rickett, D.L., and Albuquerque, E. X. (1985) The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex. Mol. Pharmacol. 28, 527–538.
Akaike, A., Ikeda, S. R., Brookes, N., Pascuzzo, G. J., Rickett, D. L., and Albuquerque, E. X. (1984) The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. II. Patch clamp studies. Mol. Pharmacol. 25, 102–112.
Albuquerque, E. X., Akaike, A., Shaw, K. P., and Rickett, D. L. (1984) The interaction of anticholinesterase agents with the acetylcholine receptor-ionic channel complex. Fundam. Appl. Toxicol. 4, S27 - S33.
Kuhlmann, J., Okonjo, K. O., and Maelicke, A. (1991) Desensitization is a property of the cholinergic binding region of the nicotinic acetylcholine receptor, not of the receptor-integral ion channel. FEBS Lett. 279, 216–218.
Eldefrawi, M. E., Eldefrawi, A. T., Aronstam, R. S., Maleque, M. A., Warnick, J. E., and Albuquerque, E. X. (1980) [3H]Phencyclidine: a probe for the ionic channel of the nicotinic receptor. Proc. Natl. Acad. Sci. USA 77, 7458–7462.
Mansour, N. A., Valdes, J. J., Shamoo, A. E., and Annau, Z. (1987) Biochemical interactions of carbamates and ecothiophate with the activated conformation of nicotinic acetylcholine receptor. J. Biochem. Toxicol. 2, 25–42.
Eldefrawi, M. E., Schweizer, G., Bakry, N. M., and Valdes, J. J. (1988) Desensitization of the nicotinic acetylcholine receptor by diisopropylfluorophosphate. J. Biochem. Toxicol. 3, 21–32.
Katz, E. J., Cortes, V. I., Eldefrawi, M. E., and Eldefrawi, A. T. (1997) Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: relevance to their toxicities. Toxicol. Appl. Pharmacol. 146, 227–236.
Volpe, L. S., Biagioni, T. M., and Marquis, J. K. (1985) In vitro modulation of bovine caudate muscarinic receptor number by organophosphates and carbamates. Toxicol. Appl. Pharmacol. 78, 226–234.
Katz, L. S. and Marquis, J. K. (1989) Modulation of central muscarinic receptor binding in vitro by ultralow levels of the organophosphate paraoxon. Toxicol. Appl. Pharmacol. 101, 114–123.
Ehrich, M., Intropido, L., and Costa, L. G. (1994) Interaction of organophosphorus compounds with muscarinic receptors in SH-SY5Y human neuroblastoma cells. J. Toxicol. Environ. Health 43, 51–63.
Fisher, S. K. (1988) Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists. Mol. Pharmacol. 33, 414–422.
Huff, R. A. and Abou-Donia, M. B. (1994) cis-Methyldioxolane specifically recognizes the m2 muscarinic receptor. J. Neurochem. 62, 388–391.
Silveira, C. L., Eldefrawi, A. T., and Eldefrawi, M. E. (1990) Putative M2 muscarinic receptors of rat heart have high affinity for organophosphorus anticholinesterases. Toxicol. Appl. Pharmacol. 103, 474–481.
Jett, D. A., Abdallah, E. A. M., El-Fakahany, E. E., Eldefrawi, M. E., and Eldefrawi, A. T. (1991) High-affinity activation by paraoxon of a muscarinic receptor subtype in rat brain striatum. Pest. Biochem. Physiol. 39, 149–157.
Ward, T. R., Ferris, D. J., Tilson, H. A., and Mundy, W. R. (1993) Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors. Toxicol. Appl. Pharmacol. 122, 300–307.
Huff, R. A., Corcoran, J. J., Anderson, J. K., and Abou-Donia, M. B. (1994) Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat stria-turn. J. Pharmacol. Exp. Ther. 269, 329–335.
Ward, T. R. and Mundy, W. R. (1996) Organophosphorus compounds preferentially affect second messenger systems coupled to M2/M4 receptors in rat frontal cortex. Brain Res. Bull. 39, 49–55.
Van Den Beukel, I., Dijcks, F. A., Vanderheyden, P., Vauquelin, G., and Oortgiesen, M. (1997) Differential muscarinic receptor binding of acetylcholinesterase inhibitors in rat brain, human brain and Chinese hamster ovary cells expressing human receptors. J. Pharmacol. Exp. Ther. 281, 1113–1119.
Cao, C. J., Mioduszewski, R. J., Menking, D. E., Valdes, J. J., Katz, E. J., Eldefrawi, M. E., and Eldefrawi, A. T. (1999) Cytotoxicity of organophosphate anticholinesterases. In vitro Cell Dev. Biol. Anim. 35, 493–500.
El-Sebae, A. H., Soliman, S. A., Ahmed, N. S., and Curley, A. (1981) Biochemical interaction of six OP delayed neurotoxicants with several neurotargets. J. Environ. Sci. Health B.J 16, 465–474.
Johnson, P. S. and Michaelis, E. K. (1992) Characterization of organophosphate interactions at N-methyl-D-aspartate receptors in brain synaptic membranes. Mol. Pharmacol. 41, 750–756.
Gant, D. B., Eldefrawi, M. E., and Eldefrawi, A. T. (1987) Action of organophosphates on GABAA receptor and voltage-dependent chloride channels. Fundam. Appl. Toxicol. 9, 698–704.
Lau, W-M, Freeman, S. E., and Szilagyi, M. (1988) Binding of some organophosphorus compounds at adenosine receptors in guinea pig brain membranes. Neurosci. Lett. 94, 125–130.
Lau, W-M, Szilagyi, M., and Freeman, S. E. (1991) Effects of some organophosphorus compounds on the binding of a radioligand (8-cyclopentyl 1,343H]dipropylxanthine) to adenosine receptors in ovine cardiac membranes. J. Appl. Toxicol. 11, 411–414.
Weiler, M. H. (1989) Muscarinic modulation of endogenous acetylcholine release in rat neostriatal slices. J. Pharmacol. Exp. Ther. 250, 617–623.
Feuerstein, T. J., Lehmann, J., Sauermann, W., van Velthoven, V., and Jackisch, R. (1992) The autoinhibitory feedback control of acetylcholine release in human neocortex tissue. Brain Res. 572, 64–71.
Kitaichi, K., Hori, T., Srivastava, L. K., and Quirion, R. (1999) Antisense oligodeoxynucleotides against the muscarinic m2, but not m4, receptor supports its role as autoreceptors in the rat hippocampus. Brain Res. Mol. Brain Res. 67, 98–106.
Watson, M., Roeske, W. R., Vickroy, T. W., Smit, T. L., Akiyama, K., Gulya, K., et al. (1986) Biochemical and functional basis of putative muscarinic receptor subtypes and its implications. Trends Pharmacol. Sci. (Suppl.) 2, 44–55.
Pope, C. N., Chakraborti, T. K., Chapman, M. L., Farrar, J. D., and Arthun, D. (1991) Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. Toxicology 68, 51–6l
Chaudhuri, J., Chakraborti, T. K., Chanda, S., and Pope, C. N. (1993) Differential modulation of organophosphate-sensitive muscarinic receptors in rat brain by parathion and chlorpyrifos. J. Biochem. Toxicol. 8, 207–216.
Liu, J. and Pope, C. N. (1996) Effects of chlorpyrifos on high-affinity choline uptake and [3H]hemicholinium-3 binding in rat brain. Fundam. Appl. Toxicol. 34, 84–90.
Pope, C. N., Chaudhuri, J., and Chakraborti, T. K. (1995) Organophosphate-sensitive cholinergic receptors: possible role in modulation of anticholinesterase toxicity, in Enzymes of the Cholinesterase Family ( Quinn, D. M., Balasubramanian, A. S., Doctor, B. P., and Taylor, P., eds.), Plenum, NY, pp. 305–312.
Liu, J. and Pope, C. N. (1998) Comparative presynaptic neurochemical changes in rat stria-turn following exposure to chlorpyrifos or parathion. J. Toxicol. Environ. Health 53, 531–544.
Cancela, J. M., Bertrand, N., and Beley, A. (1995) Involvement of cAMP in the regulation of high affinity choline uptake by rat brain synaptosomes. Biochem. Biophys. Res. Commun. 213, 944–949.
Vogelsberg, V., Neff, N. H., and Hadjiconstantinou, M. (1997) Cyclic AMP-mediated enhancement of high-affinity choline transport and acetylcholine synthesis in brain. J. Neurochem. 68, 1062–1070.
Rocha, E. S., Swanson, K. L., Aracava, Y., Goolsby, J. E., Maelicke, A., and Albuquerque, E. X. (1996a). Paraoxon: cholinesterase-independent stimulation of transmitter release and selective block of ligand-gated ion channels in cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 278, 1175–1187.
Rocha, E. S., Pereira, E. F. R., Swanson, K. L., and Albuquerque, E. X. (1996b) Novel molecular targets in the central nervous system for the actions of cholinesterase inhibitors: alterations of modulatory processes. Proceedings of the 1996 Medical Defense Bioscience Review III, pp. 1635–1643.
Dam, K., Seidler, F. J., and Slotkin, T. A. (1999) Chlorpyrifos releases norepinephrine from adult and neonatal rat brain synaptosomes. Dev. Brain Res. 118, 129–133.
Whitney, K. D., Seidler, F. J., and Slotkin, T. A. (1995) Developmental neurotoxicity of chlorpyrifos: cellular mechanisms. Toxicol. Appl. Pharmacol. 134, 53–62.
Campbell, C. G., Seidler, F. J., and Slotkin, T. A. (1997) Chlorpyrifos interferes with cell development in rat brain regions. Brain Res. Bull. 43, 179–189.
Johnson, D. E., Seidler, F. J., and Slotkin, T. A. (1998) Early biochemical detection of delayed neurotoxicity resulting from developmental exposure to chlorpyrifos. Brain Res. Bull. 45, 143–147.
Dam, K., Seidler, F. J., and Slotkin, T. A. (1998) Developmental neurotoxicity of chlorpyrifos: delayed targeting of DNA synthesis after repeated administration. Dev. Brain Res. 108, 39–45.
Song, X., Seidler, F. J., Saleh, J. L., Zhang, J., Padilla, S., and Slotkin, T. A. (1997) Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade. Toxicol. Appl. Pharmacol. 145, 158–174.
Roy, T. S., Andrews, J. E., Seidler, F. J., and Slotkin, T. A. (1998) Chlorpyrifos elicits mitotic abnormalities and apoptosis in neuroepithelium of cultured rat embryos. Teratology 58, 62–68.
Robertson, R. T. and Yu, J. (1993) Acetylcholinesterase and neural development: new tricks for an old dog? News Physiol. Sci. 8, 266–272.
Layer, P. G. and Willbold, E. (1995) Novel functions of cholinesterases in development, physiology and disease. Prog. Histochem. Cytochem. 29, 1–94.
Small, D. H., Michaelson, S., and Sberna, G. (1996) Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer’s disease. Neurochem. Int. 28, 453–483.
Kostovic, I. and Goldman-Rakic, P. S. (1983) Transient cholinesterase staining in the mediodorsal nucleus of the thalamus and its connections in the develo** human and monkey brain. J. Comp. Neurol. 219, 431–447.
Kristt, D. A. (1983) Acetylcholinesterase in the ventral thalamus: transience and patterning during ontogenesis. Neuroscience 10, 923–939.
Layer, P. G. (1990) Cholinesterases preceeding major tracts in vertebrate neurogenesis. BioEssays 12, 415–420.
Robertson, R. T., Mostamand, F., Kageyama, G. H., Gallardo, K. A., and Yu, J. (1991) Primary auditory cortex in the rat: transient expression of acetylcholinesterase activity in develo** geniculocortical projections. Brain Res. Dev. Brain Res. 58, 81–95.
Dupree, J.I. and Bigbee, J.W. (1994) Retardation of neuritic outgrowth and cytoskeletal changes accompany acetylcholinesterase inhibitor treatment in cultured rat dorsal root ganglion neurons. J. Neurosci. Res. 39, 567–575.
Layer, P. G., Weikert, T., and Alber, R. (1993) Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of a non-enzymatic mechanism. Cell. Tissue Res. 273, 219–226.
Sternfeld, M., Ming, G-L., Song, H-J., Sela, H, Timberg, R., Poo, M-M., and Soreq, H. (1998). Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein and variable C termini. J. Neurosci. 18, 1240–1249.
Saito, S. (1998) Cholinesterase inhibitors induce growth cone collapse and inhibit neurite extension in primary cultured chick neurons. Neurotoxicol. Teratol. 20, 411–419.
Henschler, D., Schmuck, G., van Aerssen, M., and Schiffmann, D. (1992) The inhibitory effect of neuropathic organophosphate esters on neurite outgrowth in cell cultures: a basis for screening for delayed neurotoxicity. Toxicol. Vitro 6, 327–325. 84.
Flaskos, J., McLean, W. G., and Hargreaves, A. J. (1994) The toxicity of organophosphate compounds toward cultured PC12 cells. Toxicol. Lett. 70, 71–76.
Li, W. and Casida, J. E. (1998) Organophosphorus neuropathy target esterase inhibitors selectively block outgrowth of neurite-like and cell processes in cultured cells. Toxicol. Lett. 98, 139–146.
Song, X., Violin, J. D., Seidler, F. J., and Slotkin. T. A. (1998) Modeling the developmental neurotoxicity of chlorpyrifos in vitro: macromolecular synthesis in PC12 cells. Toxicol. Appl. Pharmacol. 151, 182–191.
Das, K. P. and Barone, S. Jr. (1999) Neuronal differentiation in PC12 cells is inhibited by chlorpyrifos and its metabolites: is acetylcholinesterase inhibition the site of action? Toxicol. Appl. Pharmacol. 160, 217–230.
Appleyard, M. E. (1992) Secreted acetylcholinesterase: non-classical aspects of a classical enzyme. Trends Neurol. Sci. 15, 485–490.
Greenfield, S. A. (1991) A noncholinergic action of acetylcholinesterase (AChE) in the brain: from neuronal secretion to the generation of movement. Cell Mol. Neurobiol. 11, 55–77.
Greenfield, S. A., Chubb, I. W., Grunewald, R. A., Henderson, Z., May, J., Portnoy, S.,et al. (1984) A non-cholinergie function for acetylcholinesterase in the substantia nigra: behavioural evidence. Exp. Brain Res. 54, 513–520.
Appleyard, M. E., Vercher, J. L., and Greenfield, S. A. (1988) Release of acetylcholinesterase from the guinea-pig cerebellum in vivo. Neuroscience 25, 133–138.
Webb, C. P. and Greenfield, S. A. (1992) Non-cholinergic effects of acetylcholinesterase in the substantia nigra: possible role for an ATP-sensitive potassium channel. Exp. Brain Res. 89, 49–58.
Appleyard, M. and Jahnsen, H. (1992) Actions of acetylcholinesterase in the guinea-pig cerebellar cortex in vitro. Neuroscience 47, 291–301.
Webb, C. P., Nedergaard, S., Giles, K., and Greenfield, S. A. (1996) Involvement of the NMDA receptor in a non-cholinergic action of acetylcholinesterase in guinea pig subtantia nigra pars compacta neurons. Eur. J. Neurosci. 8, 837–841.
Holmes, C., Jones, S. A., Budd, T. C., and Greenfield. (1997) Non-cholinergic, trophic action of recombinant acetylcholinesterase on mid-brain dopaminergic neurons. J. Neurosci. Res. 49, 207–218.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pope, C., Liu, J. (2002). Nonesterase Actions of Anticholinesterase Insecticides. In: Massaro, E.J. (eds) Handbook of Neurotoxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-132-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-59259-132-9_3
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-193-6
Online ISBN: 978-1-59259-132-9
eBook Packages: Springer Book Archive